{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:16:01Z","timestamp":1793387761380,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-025-05339-0","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T08:21:52Z","timestamp":1743495712000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Enhancing malaria elimination in high-transmission settings: the synergy of concurrent vector control and chemotherapy"],"prefix":"10.1186","volume":"24","author":[{"given":"Ronald","family":"Mulebeke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adoke","family":"Yeka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"van Geertruyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"key":"5339_CR1","volume-title":"A framework for malaria elimination","author":"WHO","year":"2017","unstructured":"WHO. A framework for malaria elimination. Geneva: World Health Organization; 2017."},{"key":"5339_CR2","unstructured":"WHO. Global technical strategy for malaria 2016\u20132030, 2021 update. 2021."},{"key":"5339_CR3","volume-title":"World malaria report 2023","author":"WHO","year":"2023","unstructured":"WHO. World malaria report 2023. Geneva: World Health Organization; 2023."},{"key":"5339_CR4","unstructured":"WHO. Roll Back Malaria. High burden to high impact: a targeted malaria response. Report No.: WHO\/CDS\/GMP\/2018.25.Rev.1.2019."},{"key":"5339_CR5","volume-title":"Eliminating malaria","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. Eliminating malaria. Geneva: World Health Organization; 2016."},{"key":"5339_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000412","volume":"8","author":"JA N\u00e1jera","year":"2011","unstructured":"N\u00e1jera JA, Gonz\u00e1lez-Silva M, Alonso PL. Some lessons for the future from the global malaria eradication programme (1955\u20131969). PLoS Med. 2011;8: e1000412.","journal-title":"PLoS Med"},{"key":"5339_CR7","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/1475-2875-11-122","volume":"11","author":"JM Cohen","year":"2012","unstructured":"Cohen JM, Smith DL, Cotter C, Ward A, Yamey G, Sabot OJ, et al. Malaria resurgence: a systematic review and assessment of its causes. Malar J. 2012;11:122.","journal-title":"Malar J"},{"key":"5339_CR8","volume-title":"Malaria eradication: benefits, future scenarios and feasibility: a report of the Strategic Advisory Group on Malaria Eradication","author":"WHO","year":"2020","unstructured":"WHO. Malaria eradication: benefits, future scenarios and feasibility: a report of the Strategic Advisory Group on Malaria Eradication. New Delhi, India: World Health Organization, Regional Office for South-East Asia; 2020."},{"key":"5339_CR9","volume-title":"Global malaria control and elimination: report of a technical review","author":"WHO","year":"2008","unstructured":"WHO. Global malaria control and elimination: report of a technical review. Geneva: World Health Organization; 2008."},{"key":"5339_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40249-019-0542-8","volume":"8","author":"M Ren","year":"2019","unstructured":"Ren M. Greater political commitment needed to eliminate malaria. Infect Dis Poverty. 2019;8:28.","journal-title":"Infect Dis Poverty"},{"key":"5339_CR11","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/S0140-6736(10)61551-6","volume":"376","author":"P Das","year":"2010","unstructured":"Das P, Horton R. Malaria elimination: worthy, challenging, and just possible. Lancet. 2010;376:1515\u20137.","journal-title":"Lancet"},{"key":"5339_CR12","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.pt.2016.11.006","volume":"33","author":"IN Nkumama","year":"2017","unstructured":"Nkumama IN, O\u2019Meara WP, Osier FHA. Changes in malaria epidemiology in Africa and new challenges for elimination. Trends Parasitol. 2017;33:128\u201340.","journal-title":"Trends Parasitol"},{"key":"5339_CR13","first-page":"21","volume":"107","author":"MR Kamya","year":"2024","unstructured":"Kamya MR, Nankabirwa JI, Arinaitwe E, Rek J, Zedi M, Maiteki-Sebuguzi C, et al. Dramatic resurgence of malaria after 7 years of intensive vector control interventions in Eastern Uganda. MedRxiv. 2024;107:21.","journal-title":"MedRxiv"},{"key":"5339_CR14","doi-asserted-by":"publisher","first-page":"e474","DOI":"10.1016\/S2214-109X(16)30073-0","volume":"4","author":"PGT Walker","year":"2016","unstructured":"Walker PGT, Griffin JT, Ferguson NM, Ghani AC. Estimating the most efficient allocation of interventions to achieve reductions in Plasmodium falciparum malaria burden and transmission in Africa: a modelling study. Lancet Glob Health. 2016;4:e474\u201384.","journal-title":"Lancet Glob Health"},{"key":"5339_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40249-019-0524-x","volume":"8","author":"S Dhiman","year":"2019","unstructured":"Dhiman S. Are malaria elimination efforts on right track? An analysis of gains achieved and challenges ahead. Infect Dis Poverty. 2019;8:14.","journal-title":"Infect Dis Poverty"},{"key":"5339_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2022.104366","volume":"81","author":"HJ Oladipo","year":"2022","unstructured":"Oladipo HJ, Tajudeen YA, Oladunjoye IO, Yusuff SI, Yusuf RO, Oluwaseyi EM, et al. Increasing challenges of malaria control in sub-Saharan Africa: priorities for public health research and policymakers. Ann Med Surg. 2022;81: 104366.","journal-title":"Ann Med Surg"},{"key":"5339_CR17","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s40121-022-00647-3","volume":"11","author":"JC Semenza","year":"2022","unstructured":"Semenza JC, Rockl\u00f6v J, Ebi KL. Climate change and cascading risks from infectious disease. Infect Dis Ther. 2022;11:1371\u201390.","journal-title":"Infect Dis Ther"},{"key":"5339_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.2122","volume":"7","author":"L Lawal","year":"2024","unstructured":"Lawal L, Buhari AO, Jaji TA, Alatare AS, Adeyemo AO, Olumoh AO, et al. Lingering challenges in malaria elimination efforts insub-Saharan Africa: insights and potential solutions. Health Sci Rep. 2024;7: e2122.","journal-title":"Health Sci Rep"},{"key":"5339_CR19","doi-asserted-by":"publisher","first-page":"3862","DOI":"10.1038\/s41467-022-30700-1","volume":"13","author":"E Sherrard-Smith","year":"2022","unstructured":"Sherrard-Smith E, Ngufor C, Sanou A, Guelbeogo MW, N\u2019Guessan R, Elobolobo E, et al. Inferring the epidemiological benefit of indoor vector control interventions against malaria from mosquito data. Nat Commun. 2022;13:3862.","journal-title":"Nat Commun"},{"key":"5339_CR20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12936-019-2835-6","volume":"18","author":"N Kaehler","year":"2019","unstructured":"Kaehler N, Adhikari B, Cheah PY, von Seidlein L, Day NPJ, Paris DH, et al. Prospects and strategies for malaria elimination in the Greater Mekong Sub-region: a qualitative study. Malar J. 2019;18:203.","journal-title":"Malar J"},{"key":"5339_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002380","volume":"14","author":"J Hemingway","year":"2016","unstructured":"Hemingway J, Shretta R, Wells TNC, Bell D, Djimd\u00e9 AA, Achee N, et al. Tools and strategies for malaria control and elimination: what do we need to achieve a grand convergence in malaria? PLoS Biol. 2016;14: e1002380.","journal-title":"PLoS Biol"},{"key":"5339_CR22","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s12936-024-05215-3","volume":"23","author":"D Lek","year":"2024","unstructured":"Lek D, Shrestha M, Lhazeen K, Tobgyel T, Kandel S, Dahal G, et al. Malaria elimination challenges in countries approaching the last mile: a discussion among regional stakeholders. Malar J. 2024;23:401.","journal-title":"Malar J"},{"key":"5339_CR23","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12936-023-04696-y","volume":"22","author":"Y Chen","year":"2023","unstructured":"Chen Y, Zhang H, Chen H, Fan L, Xu C, Xu J, et al. Malaria epidemiological characteristics and control in Guangzhou, China, 1950\u20132022. Malar J. 2023;22:265.","journal-title":"Malar J"},{"key":"5339_CR24","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1186\/s13071-019-3753-8","volume":"12","author":"C Antonio-Nkondjio","year":"2019","unstructured":"Antonio-Nkondjio C, Ndo C, Njiokou F, Bigoga JD, Awono-Ambene P, Etang J, et al. Review of malaria situation in Cameroon: technical viewpoint on challenges and prospects for disease elimination. Parasit Vectors. 2019;12:501.","journal-title":"Parasit Vectors"},{"key":"5339_CR25","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s12936-020-03407-1","volume":"19","author":"C Karema","year":"2020","unstructured":"Karema C, Wen S, Sidibe A, Smith JL, Gosling R, Hakizimana E, et al. History of malaria control in Rwanda: implications for future elimination in Rwanda and other malaria-endemic countries. Malar J. 2020;19:356.","journal-title":"Malar J"},{"key":"5339_CR26","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1186\/s12889-021-12036-5","volume":"21","author":"D Nega","year":"2021","unstructured":"Nega D, Abera A, Gidey B, Mekasha S, Abebe A, Dillu D, et al. Baseline malaria prevalence at the targeted pre-elimination districts in Ethiopia. BMC Public Health. 2021;21:1996.","journal-title":"BMC Public Health"},{"key":"5339_CR27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12936-018-2244-2","volume":"17","author":"G Gachelin","year":"2018","unstructured":"Gachelin G, Garner P, Ferroni E, Verhave JP, Opinel A. Evidence and strategies for malaria prevention and control: a historical analysis. Malar J. 2018;17:96.","journal-title":"Malar J"},{"key":"5339_CR28","first-page":"CD000363","volume":"2","author":"C Lengeler","year":"2004","unstructured":"Lengeler C. Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database Syst Rev. 2004;2:CD000363.","journal-title":"Cochrane Database Syst Rev"},{"key":"5339_CR29","volume-title":"Indoor residual spraying: an operational manual for indoor residual spraying (IRS) for malaria transmission control and elimination","author":"WHO","year":"2015","unstructured":"WHO. Indoor residual spraying: an operational manual for indoor residual spraying (IRS) for malaria transmission control and elimination. Geneva: World Health Organization; 2015."},{"key":"5339_CR30","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1016\/S2542-5196(21)00296-5","volume":"6","author":"E Sherrard-Smith","year":"2022","unstructured":"Sherrard-Smith E, Winskill P, Hamlet A, Ngufor C, N\u2019Guessan R, Guelbeogo MW, et al. Optimising the deployment of vector control tools against malaria: a data-informed modelling study. Lancet Planet Health. 2022;6:e100\u20139.","journal-title":"Lancet Planet Health"},{"key":"5339_CR31","first-page":"CD012688","volume":"1","author":"J Pryce","year":"2022","unstructured":"Pryce J, Medley N, Choi L. Indoor residual spraying for preventing malaria in communities using insecticide-treated nets. Cochrane Database Syst Rev. 2022;1:CD012688.","journal-title":"Cochrane Database Syst Rev"},{"key":"5339_CR32","doi-asserted-by":"publisher","first-page":"857","DOI":"10.4269\/ajtmh.13-0129","volume":"89","author":"JA Flegg","year":"2013","unstructured":"Flegg JA, Metcalf CJE, Gharbi M, Venkatesan M, Shewchuk T, Hopkins Sibley C, et al. Trends in Antimalarial Drug Use in Africa. Am J Trop Med Hyg. 2013;89:857\u201365.","journal-title":"Am J Trop Med Hyg"},{"issue":"6_Suppl","key":"5339_CR33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.4269\/ajtmh.2007.77.193","volume":"77","author":"A Bosman","year":"2007","unstructured":"Bosman A, Mendis KN. A major transition in malaria treatment: the adoption and deployment of artemisinin-based combination therapies. Am J Trop Med Hyg. 2007;77(6_Suppl):193\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"5339_CR34","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1172\/JCI21682","volume":"113","author":"NJ White","year":"2004","unstructured":"White NJ. Antimalarial drug resistance. J Clin Invest. 2004;113:1084\u201392.","journal-title":"J Clin Invest"},{"key":"5339_CR35","volume":"2011","author":"M Nanyunja","year":"2011","unstructured":"Nanyunja M, Nabyonga Orem J, Kato F, Kaggwa M, Katureebe C, Saweka J. Malaria treatment policy change and implementation: the case of Uganda. Malar Res Treat. 2011;2011: 683167.","journal-title":"Malar Res Treat"},{"key":"5339_CR36","volume-title":"Mass drug administration for falciparum malaria: a practical field manual","author":"WHO","year":"2017","unstructured":"WHO. Mass drug administration for falciparum malaria: a practical field manual. Geneva: World Health Organization; 2017."},{"key":"5339_CR37","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4269\/ajtmh.14-0254","volume":"93","author":"G Newby","year":"2015","unstructured":"Newby G, Hwang J, Koita K, Chen I, Greenwood B, von Seidlein L, et al. Review of mass drug administration for malaria and its operational challenges. Am J Trop Med Hyg. 2015;93:125\u201334.","journal-title":"Am J Trop Med Hyg"},{"key":"5339_CR38","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12936-019-2906-8","volume":"18","author":"TP Eisele","year":"2019","unstructured":"Eisele TP. Mass drug administration can be a valuable addition to the malaria elimination toolbox. Malar J. 2019;18:281.","journal-title":"Malar J"},{"key":"5339_CR39","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1016\/S1473-3099(16)30269-9","volume":"17","author":"NJ White","year":"2017","unstructured":"White NJ. Does antimalarial mass drug administration increase or decrease the risk of resistance? Lancet Infect Dis. 2017;17:e15-20.","journal-title":"Lancet Infect Dis"},{"key":"5339_CR40","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/cid\/ciy870","volume":"69","author":"J Mwesigwa","year":"2019","unstructured":"Mwesigwa J, Achan J, Affara M, Wathuo M, Worwui A, Mohammed NI, et al. Mass drug administration with dihydroartemisinin-piperaquine and malaria transmission dynamics in The Gambia: a prospective cohort study. Clin Infect Dis. 2019;69:278\u201386.","journal-title":"Clin Infect Dis"},{"key":"5339_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00741-2","author":"E-hKC Ba","year":"2025","unstructured":"Ba E-hKC, Roh ME, Diallo A, Gadiaga T, Seck A, Thiam S, et al. Effect of mass drug administration on malaria incidence in southeast Senegal during 2020\u201322: a two-arm, open-label, cluster-randomised controlled trial. Lancet Infect Dis. 2025. https:\/\/doi.org\/10.1016\/S1473-3099(24)00741-2.","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 4","key":"5339_CR42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4269\/ajtmh.22-0766","volume":"110","author":"ZD Schneider","year":"2024","unstructured":"Schneider ZD, Shah MP, Boily MC, Busbee AL, Hwang J, Lindblade KA, et al. Mass drug administration to reduce malaria transmission: a systematic review and meta-analysis. Am J Trop Med Hyg. 2024;110(Suppl 4):17\u201329.","journal-title":"Am J Trop Med Hyg"},{"key":"5339_CR43","doi-asserted-by":"publisher","first-page":"e680","DOI":"10.1016\/S2214-109X(17)30220-6","volume":"5","author":"OJ Brady","year":"2017","unstructured":"Brady OJ, Slater HC, Pemberton-Ross P, Wenger E, Maude RJ, Ghani AC, et al. Role of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling study. Lancet Glob Health. 2017;5:e680\u20137.","journal-title":"Lancet Glob Health"},{"key":"5339_CR44","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.51773","volume":"9","author":"B Gao","year":"2020","unstructured":"Gao B, Saralamba S, Lubell Y, White LJ, Dondorp AM, Aguas R. Determinants of MDA impact and designing MDAs towards malaria elimination. Elife. 2020;9: e51773.","journal-title":"Elife"},{"key":"5339_CR45","volume-title":"Guidelines for malaria","author":"WHO","year":"2024","unstructured":"WHO. Guidelines for malaria. Geneva: World Health Organization; 2024."},{"key":"5339_CR46","volume-title":"WHO recommends R21\/Matrix-M vaccine for malaria prevention in updated advice on immunization","author":"WHO","year":"2023","unstructured":"WHO. WHO recommends R21\/Matrix-M vaccine for malaria prevention in updated advice on immunization. Geneva: World Health Organization; 2023."},{"key":"5339_CR47","volume-title":"Full evidence report on the RTS, S\/AS01 malaria vaccine","author":"WHO","year":"2021","unstructured":"WHO. Full evidence report on the RTS, S\/AS01 malaria vaccine. Geneva: World Health Organization; 2021."},{"key":"5339_CR48","doi-asserted-by":"publisher","first-page":"e0296934","DOI":"10.1371\/journal.pone.0296934","volume":"19","author":"SA Saaka","year":"2024","unstructured":"Saaka SA, Mohammed K, Pienaah CKA, Luginaah I. Child malaria vaccine uptake in Ghana: Factors influencing parents\u2019 willingness to allow vaccination of their children under five (5) years. PLoS ONE. 2024;19:e0296934.","journal-title":"PLoS ONE"},{"key":"5339_CR49","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S0140-6736(23)02716-2","volume":"403","author":"CA Nnaji","year":"2024","unstructured":"Nnaji CA, Amaechi UA, Wiysonge CS. R21\/Matrix-M vaccine: optimising supply, maximising impact. Lancet. 2024;403:525.","journal-title":"Lancet"},{"key":"5339_CR50","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12916-024-03321-2","volume":"22","author":"F Amimo","year":"2024","unstructured":"Amimo F. Malaria vaccination: hurdles to reach high-risk children. BMC Med. 2024;22:111.","journal-title":"BMC Med"},{"key":"5339_CR51","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12936-024-04938-7","volume":"23","author":"AJ Simbeye","year":"2024","unstructured":"Simbeye AJ, Kumwenda S, Cohee LM, Omondi D, Masibo PK, Wao H, et al. Factors associated with malaria vaccine uptake in Nsanje district. Malawi Malar J. 2024;23:105.","journal-title":"Malawi Malar J"},{"key":"5339_CR52","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1073\/pnas.1409467112","volume":"112","author":"Y Artzy-Randrup","year":"2015","unstructured":"Artzy-Randrup Y, Dobson AP, Pascual M. Synergistic and antagonistic interactions between bednets and vaccines in the control of malaria. Proc Natl Acad Sci USA. 2015;112:3014\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5339_CR53","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12936-019-2788-9","volume":"18","author":"RC Elliott","year":"2019","unstructured":"Elliott RC, Smith DL, Echodu DC. Synergy and timing: a concurrent mass medical campaign predicted to augment indoor residual spraying for malaria. Malar J. 2019;18:160.","journal-title":"Malar J"},{"key":"5339_CR54","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12936-023-04564-9","volume":"22","author":"M Runge","year":"2023","unstructured":"Runge M, Stahlfeld A, Ambrose M, Toh KB, Rahman S, Omoniwa OF, et al. Perennial malaria chemoprevention with and without malaria vaccination to reduce malaria burden in young children: a modelling analysis. Malar J. 2023;22:133.","journal-title":"Malar J"},{"key":"5339_CR55","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(18)30427-6","volume":"391","author":"N Protopopoff","year":"2018","unstructured":"Protopopoff N, Mosha JF, Lukole E, Charlwood JD, Wright A, Mwalimu CD, et al. Effectiveness of a long-lasting piperonyl butoxide-treated insecticidal net and indoor residual spray interventions, separately and together, against malaria transmitted by pyrethroid-resistant mosquitoes: a cluster, randomised controlled, two-by-two factorial design trial. Lancet. 2018;391:1577\u201388.","journal-title":"Lancet"},{"key":"5339_CR56","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/s12936-023-04799-6","volume":"22","author":"R Mulebeke","year":"2023","unstructured":"Mulebeke R, Wanzira H, Adoke Y, Van Geertruyden JP. Impact of population based indoor residual spraying in combination with mass drug administration on malaria incidence and test positivity in a high transmission setting in north eastern Uganda. Malar J. 2023;22:378.","journal-title":"Malar J"},{"key":"5339_CR57","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12879-023-07991-w","volume":"23","author":"DC Echodu","year":"2023","unstructured":"Echodu DC, Yeka A, Eganyu T, Odude W, Bukenya F, Amoah B, et al. Impact of population based indoor residual spraying with and without mass drug administration with dihydroartemisinin-piperaquine on malaria prevalence in a high transmission setting: a quasi-experimental controlled before-and-after trial in northeastern Uganda. BMC Infect Dis. 2023;23:72.","journal-title":"BMC Infect Dis"},{"key":"5339_CR58","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1473-3099(23)00368-7","volume":"24","author":"A Dicko","year":"2024","unstructured":"Dicko A, Ouedraogo JB, Zongo I, Sagara I, Cairns M, Yerbanga RS, et al. Seasonal vaccination with RTS, S\/AS01(E) vaccine with or without seasonal malaria chemoprevention in children up to the age of 5 years in Burkina Faso and Mali: a double-blind, randomised, controlled, phase 3 trial. Lancet Infect Dis. 2024;24:75\u201386.","journal-title":"Lancet Infect Dis"},{"key":"5339_CR59","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S1473-3099(23)00392-4","volume":"24","author":"S Dutta","year":"2024","unstructured":"Dutta S, Thera MA. Seasonal RTS, S\/AS01(E) vaccination with or without seasonal malaria chemoprevention. Lancet Infect Dis. 2024;24:9\u201311.","journal-title":"Lancet Infect Dis"},{"key":"5339_CR60","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.chom.2022.04.004","volume":"30","author":"NN Nkomba","year":"2022","unstructured":"Nkomba NN, Cairo C, Laufer MK. RTS, S today and tomorrow\u2019s science. Cell Host Microbe. 2022;30:604\u20136.","journal-title":"Cell Host Microbe"},{"key":"5339_CR61","doi-asserted-by":"crossref","unstructured":"malERA. An updated research agenda for insecticide and drug resistance in malaria elimination and eradication. PLoS Med. 2017;14:e1002450.","DOI":"10.1371\/journal.pmed.1002450"},{"key":"5339_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-024-05235-z","volume":"24","author":"O Sibomana","year":"2025","unstructured":"Sibomana O, Bukuru J, Saka SA, Uwizeyimana MG, Kihunyu AM, Obianke A, et al. Routine malaria vaccination in Africa: a step toward malaria eradication? Malar J. 2025;24:1.","journal-title":"Malar J"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05339-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05339-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05339-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T17:11:54Z","timestamp":1743700314000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-025-05339-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5339"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05339-0","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"2 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"105"}}